Responding to a question about whether there were any plans for a public listing of Patanjali Ayurved, Baba Ramdev on Wednesday (12 December) indicated that the company would announce some “good news” relating to the same in a month or so, reports Economic Times.
Patanjali Ayurved has grown at breakneck speed in recent years to challenge the market dominance of multi-national FMCGs in a variety of sectors. The home-grown company has grown to Rs 10,000 crores in revenue in FY16 from just Rs 500 crores in FY12.
The company has plans to double its annual revenues within three to five years from now. But recently, a surprise fall in sales has put the breaks on the company’s rapid rise. Patanjali’s standalone consumer goods revenue fell to Rs 8,148 in the year ended March 2018, a decline of greater than 10 per cent.
A report by CARE Ratings attributed the declining sales numbers to the company’s failure to adapt quickly enough after the introduction of GST and its inability to properly develop its distribution network.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.